Crypto Company Bankruptcy Saga Shows Exchanges Should Stop “Operating As Banks”

After a nuclear explosion of a collapse, FTX is now crypto history. However, the ramifications of its $32 billion bankruptcy and alleged fraud go beyond its four walls and SBF’s potential prison time. In both related and unrelated fashion, FTX is now the first of several companies to join the crypto company bankruptcy saga.

Other crypto exchanges like Bitfront are filing for bankruptcy, citing their own separate financial challenges. Bitfront is suspending all credit card payments and new sign-ups, planning to close up shop for good in the next few months.

Another major player, BlockFi, is collapsing specifically under the weigh of FTX’s bankruptcy. $30 million in the red with the SEC, the cryptocurrency lending platform now leaves over 100,00 creditors out to dry, citing FTX’s bankruptcy as the last straw that pushed forced BlockFi to also file Chapter 11. While BlockFi was facing some already-present financial hardships with crypto market dips and massive layoffs that cut the company’s workforce down by 20% in June 2022, the company reached out to FTX for a $400 million line of credit. Naturally, when FTX filed for bankruptcy, this pushed BlockFi’s liquidity crisis over the edge.

Kelly Massad, CEO of Maintay Digital, a blockchain and Web3 native company that “focuses on demystifying blockchain capabilities for enterprises,” sees these falling dominoes as a fundamental strategic error on the part of crypto companies.

Kelly’s Thoughts

“It really just boils down to liabilities, the exceeding assets. These companies are trying to operate as banks when they should be operating as the exchanges that they have signed up to be. You’re seeing a lot of this happen in the stock market, the AMC and GameStop sagas of last year where exchanges are starting to take on more risk than is really viable when it comes to trading these assets that are speculative in nature.

And it’s really coming to a head at this point, and that’s why they say ‘not your keys, not your crypto.’ So when people are starting to think about the vehicles in which they invest in, they really need to start thinking twice about taking custody of those coins and keeping that in mind going forward.”

Follow us on social media for the latest updates in B2B!

Image

Latest

Doable
Rethinking Leadership: Why “Doable” Might Be the Most Powerful Strategy in Education Today
April 3, 2026

At a time when educator burnout is rising and schools across the U.S. are facing ongoing teacher shortages, leaders are being forced to rethink what sustainable success actually looks like. Research shows that teacher attrition is closely tied to working conditions, job-related stress, and workload demands. As districts push for innovation, data-driven instruction, and…

Read More
Casey Brown
From Poverty to Pricing Power | Why Great Companies Undercharge
April 2, 2026

Casey Brown didn’t grow up thinking she would become an entrepreneur. She grew up in a blue-collar family where money was always tight — close enough to the edge that the fear of poverty shaped many of her early decisions. That fear led her into engineering, into corporate America, and eventually into a moment…

Read More
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
April 2, 2026

In this episode of Care Anywhere, host Lea Sims sits down with Nigerian nurse entrepreneur and advocate Obafemi Arowosegbe to discuss leadership, mentorship, and the future of nursing in Africa. While still a nursing student, Obafemi founded the Nightingale Summit, a growing conference designed to empower nursing students and early-career nurses with leadership skills,…

Read More
Oncology
From Denial to Access: Rethinking Oncology Care Through AI, Clinical Trials, and Patient-Centered Innovation
April 1, 2026

The rapid expansion of precision medicine, biologics, and targeted cancer therapies is transforming oncology—but it’s also overwhelming a system not built to keep pace. In the U.S., cancer drugs now account for some of the highest-cost treatments in healthcare, and with that has come a surge in prior authorization requirements and denials. Studies suggest physicians…

Read More